Anti-VEGF treatment using, e.g., bevacizumab of NF2-VS has been used in adults to stabilize tumor growth to sustain or improve hearing function, but mostly it was applied to non-operated larger tumors [16, 22, 23]. This evidence concerns the gene VEGFA and neoplasm.